The new at-home medication solution offers a high-touch, data-driven alternative to fragmented pharmacy experiences VIENNA, Va.–(BUSINESS WIRE)–Clarest Health, The new at-home medication solution offers a high-touch, data-driven alternative to fragmented pharmacy experiences VIENNA, Va.–(BUSINESS WIRE)–Clarest Health,

Clarest Health Launches “Clarest at Home,” Closing the Gap in Medication Management from Facility to Front Door

2026/02/04 22:19
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The new at-home medication solution offers a high-touch, data-driven alternative to fragmented pharmacy experiences

VIENNA, Va.–(BUSINESS WIRE)–Clarest Health, a leader in personalized medication management, announced the launch of Clarest at Home, a comprehensive at-home medication care solution. This offering is designed to support the growing population of older Americans managing complex chronic conditions and multiple medications. By extending its expert pharmacy services beyond long-term care (LTC) and post-acute facilities directly into the home, Clarest Health now provides a seamless, end-to-end ecosystem that rivals existing market solutions.

As healthcare moves toward value-based care, the transition from facility to home remains a critical vulnerability. Clarest at Home addresses this by combining advanced technology with proactive, pharmacist-led interventions to reduce confusion, ensure medication adherence, decrease hospital readmissions, and lower the total cost of care for patients and the healthcare organizations that serve them.

Leveraging Clarest’s deep roots in the LTC and post-acute sectors (through divisions like ProCare and Remedi), this new solution ensures that the high-level clinical oversight patients receive in a facility continues after discharge.

“In a healthcare landscape often paralyzed by fragmentation, true innovation isn’t just about new technology. It’s about connectivity,” said Hammad Shah, CEO of Clarest Health. “With the launch of Clarest at Home, we are not merely entering the home care market; we are closing the loop on the care continuum. We are moving from a transactional pharmacy model to a longitudinal outcomes model, ensuring that ‘patient-centricity’ is an operational reality, not just a buzzword. We are empowering patients, especially older adults who want to age at home, to bring the safety and precision of a clinical setting into their living rooms.”

Clarest at Home operates in concert with Clarest’s existing portfolio, including Clarest Path (comprehensive medication management) and its facility-based pharmacy services. This interoperability allows health plans and healthcare providers to manage a patient’s entire medication journey through a single partner, rather than fragmenting care across multiple vendors.

About Clarest Health

Clarest Health is a leader in personalized medication management, leveraging advanced technology and deep clinical expertise to improve medication adherence and safety for patients and providers across the care continuum. From specialized pharmacy services for long-term care facilities to comprehensive in-home medication support and comprehensive medication management for payers, our integrated solutions are designed to advance patient health at every step, at scale. Through our adherence technologies and data-driven approach, we provide clarity and support that empower better outcomes, reduce risk, and ensure individuals live healthier lives.

For more information about Clarest at Home, visit https://clarest.com/clarest-at-home/.

Contacts

Media Contact:
Nishta Giallorenzo
nishta.giallorenzo@clarest.com

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Stunning 96% Surge And 50% Plunge Define Volatile Market Session

Stunning 96% Surge And 50% Plunge Define Volatile Market Session

The post Stunning 96% Surge And 50% Plunge Define Volatile Market Session appeared on BitcoinEthereumNews.com. Crypto Gainers And Losers: Stunning 96% Surge And
Share
BitcoinEthereumNews2026/04/03 09:20
BitGo Holdings (BTGO) Stock Climbs Following Launch of Institutional Stablecoin Platform

BitGo Holdings (BTGO) Stock Climbs Following Launch of Institutional Stablecoin Platform

BitGo Holdings (BTGO) stock climbs as the company launches BitGo Mint, streamlining stablecoin operations for institutional clients. The post BitGo Holdings (BTGO
Share
Blockonomi2026/04/02 21:13
Coinbase adds USDC lending with Morpho on Base

Coinbase adds USDC lending with Morpho on Base

The post Coinbase adds USDC lending with Morpho on Base appeared on BitcoinEthereumNews.com. Coinbase will introduce USDC lending directly within its app, allowing users to earn yields as high as 10.8% through a new onchain integration with Morpho, the company said on Thursday. The feature, which will roll out to customers in the US (excluding New York), Bermuda, and other jurisdictions over the coming weeks, enables users to lend their USDC to borrowers on Base, Coinbase’s layer-2 blockchain. The lending system works by creating a smart contract wallet that connects to the Morpho protocol, with Steakhouse Financial managing onchain vaults that allocate liquidity across multiple markets. This design is meant to optimize returns while preserving user access to funds, which can be withdrawn when liquidity is available. Coinbase emphasized that despite the complexity of decentralized finance (DeFi), the integration will maintain the platform’s familiar interface and security features. USDC, a stablecoin redeemable 1:1 for U.S. dollars, already provides Coinbase users with passive rewards of 4.1% APY, or 4.5% for Coinbase One members. The lending expansion marks a push to increase earnings potential for holders of the asset, which has a circulating supply of more than $73 billion. Subheading updated 9/18/25 at 1:02 p.m. to correct a typo in yield percentage. This article was generated with the assistance of AI and reviewed by editor Jeffrey Albus before publication. Get the news in your inbox. Explore Blockworks newsletters: Source: https://blockworks.co/news/coinbase-usdc-onchain
Share
BitcoinEthereumNews2025/09/19 01:13

Trade GOLD, Share 1,000,000 USDT

Trade GOLD, Share 1,000,000 USDTTrade GOLD, Share 1,000,000 USDT

0 fees, up to 1,000x leverage, deep liquidity